Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 5/2014

01-05-2014 | Research Article

Metabolism of benzo(a)pyrene by subcellular fractions of gastrointestinal (GI) tract and liver in Apc Min mouse model of colon cancer

Authors: Jane A. Mantey, Perumalla V. Rekhadevi, Deacqunita L. Diggs, Aramandla Ramesh

Published in: Tumor Biology | Issue 5/2014

Login to get access

Abstract

Given the fact that increased dietary intake of polycyclic aromatic hydrocarbons (PAHs; a family of environmental toxicants) leads to the formation and development of colon tumors, the ability of the gastrointestinal tract to process these compounds is important from the viewpoint of toxicity/carcinogenesis. Benzo(a)pyrene (BaP), a prototypical PAH compound is released into the environment from automobile exhausts, cigarette smoke, and industrial emissions. Additionally, considerable intake of BaP is expected in people who consume barbecued foods and a diet rich in saturated fat. In exposed animals, BaP becomes activated to potent metabolites that interfere with target organ function and as a consequence cause toxicity and cancer. Therefore, knowledge of BaP metabolism in the digestive system will be of importance in the management of cancers of the digestive tract. The objective of our study was to study the metabolism of BaP by subcellular fractions (nuclear, cytosolic, mitochondrial, and microsomal) of the gastrointestinal tract and liver. Subcellular fractions were isolated by differential centrifugation from the stomach, jejunum, colon, and liver tissues of Apc Min mice that received a subchronic dose of 25 μg/kg BaP. The fractions were incubated with 1 and 3 μM BaP. Subsequent to incubation, samples were extracted with ethyl acetate and analyzed for BaP metabolites by reverse-phase HPLC equipped with fluorescence detection. Among the different fractions tested, microsomal BaP metabolism was higher than the rest of the fractions in all the samples analyzed. Additionally, a BaP exposure concentration-dependent effect on metabolite levels generated by the subcellular fractions was recorded. The BaP metabolites identified were the following: BaP-9,10-diol; BaP-4,5-diol; BaP-7,8-diol; 9(OH) BaP; 3(OH) BaP; BaP-3,6-dione; and BaP-6,12-dione. While the diol group of metabolites was frequently detected, among diones, the 3,6 and 6,12-dione metabolites were infrequently detected. Among the diol metabolites, the preponderance of BaP-7,8-dihydrodiol is interesting, since this metabolite is a precursor to the DNA-reactive BaP-7,8-dihydrodiol epoxide (BPDE) that has been linked to BaP-induced cancer.
Literature
1.
2.
3.
Hagland HR, Berg M, Jolma IW, Carlsen A, Søreide K. Molecular pathways and cellular metabolism in colorectal cancer. Dig Surg. 2013;30:12–25.CrossRefPubMed
4.
Miller PE, Lazarus P, Lesko SM, Cross AJ, Sinha R, Laio J, et al. Meat-related compounds and colorectal cancer risk by anatomical subsite. Nutr Cancer. 2013;65:202–26.CrossRefPubMedPubMedCentral
5.
Diggs DL, Huderson AC, Harris KL, Myers JN, Banks LD, Rekhadevi PV, et al. Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2011;29:324–57.CrossRefPubMedPubMedCentral
6.
Sinha R, Kulldorff M, Gunter MJ, Strickland P, Rothman N. Dietary benzo[a]pyrene intake and risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2005;14:2030–4.CrossRefPubMed
7.
Gunter MJ, Probst-Hensch NM, Cortessis VK, et al. Meat intake, cooking-related mutagens and risk of colorectal adenoma in a sigmoidoscopy-based case–control study. Carcinogenesis. 2005;26:637–42.CrossRefPubMed
8.
Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol. 2004;23:301–33.CrossRefPubMed
9.
Ramesh A, Archibong A, Hood DB, Guo Z, Loganathan BG. Global environmental distribution and human health effects of polycyclic aromatic hydrocarbons. In: Loganathan BG & Lam PK-S, editors. Global Contamination Trends of Persistent Organic Chemicals Florida: Taylor & Francis; 2011. p. 97–126.
10.
Harris KL, Banks LD, Mantey JA, Huderson AC, Ramesh A. Bioaccessibility of polycyclic aromatic hydrocarbons: relevance to toxicity and carcinogenesis. Expert Opin Drug Metab Toxicol. 2013;9:1465–80.CrossRefPubMedPubMedCentral
11.
Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol. 2001;39:423–36.CrossRefPubMed
12.
Chen BH, Lin YS. Formation of polycyclic aromatic hydrocarbons during processing of duck meat. J Agric Food Chem. 1997;45:1394–403.CrossRef
13.
Aaslyng MD, Duedahl-Olesen L, Jensen K, et al. Content of heterocyclic amines and polycyclic aromatic hydrocarbons in pork, beef and chicken barbecued at home by Danish consumers. Meat Sci. 2013;93:85–91.CrossRefPubMed
14.
Halberg RB, Larsen MC, Elmergreen TL, et al. Cyp1b1 exerts opposing effects on intestinal tumorigenesis via exogenous and endogenous substrates. Cancer Res. 2008;68:7394–402.CrossRefPubMedPubMedCentral
15.
Harris DL, Washington MK, Hood DB, et al. Dietary fat influenced development of colon neoplasia in Apc Min mice exposed to benzo(a)pyrene. Toxicol Pathol. 2009;37:938–46.CrossRefPubMedPubMedCentral
16.
Diggs DL, Myers JN, Banks LD, et al. Influence of dietary fat type on benzo(a)pyrene [BaP] biotransformation in a BaP-induced mouse model of colon cancer. J Nutr Biochem. 2013;24:2051–63.CrossRefPubMedPubMedCentral
17.
Huderson AC, Myers JN, Niaz MS, Washington MK, Ramesh A. Chemoprevention of benzo(a)pyrene-induced colon polyps in Apc Min mice by resveratrol. J Nutr Biochem. 2013;24:713–24.CrossRefPubMed
18.
Cavret S, Rychen G, Feidt C. In vitro intestinal transfer and metabolism of polycyclic aromatic hydrocarbons. Polycycl Aromat Compd. 2004;24:513–25.CrossRef
19.
Betton GR. A review of the toxicology and pathology of the gastrointestinal tract. Cell Biol Toxicol. 2013;29:321–38.CrossRefPubMed
20.
Barrowman JA, Rahman A, Lindstrom MB, Borgstrom B. Intestinal absorption and metabolism of hydrocarbons. Prog Lipid Res. 1989;28:189–203.CrossRefPubMed
21.
Wang HS, Man YB, Wu FY et al. Oral bioaccessibility of polycyclic aromatic hydrocarbons (PAHs) through fish consumption, based on an in vitro digestion model. J Agric Food Chem. 2010;58:11517–24.
22.
Yu YX, Chen L, Yang D, et al. Polycyclic aromatic hydrocarbons in animal-based foods from Shanghai: bioaccessibility and dietary exposure. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29:1465–74.CrossRefPubMed
23.
Ekins S, Ring BJ, Grace J, et al. Present and future in vitro approaches for drug metabolism. J Pharmacol Toxicol Methods. 2000;44:313–24.CrossRefPubMed
24.
National Research Council [NRC]. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
25.
Ades IZ, Cascarano J. Characterization of cytochrome oxidase purified from rat liver. Bioenerg Biomembr. 1977;9:237–53.CrossRef
26.
Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein, utilizing the principle of dye binding. Anal Biochem. 1976;72:248–54.CrossRefPubMed
27.
Ramesh A, Inyang F, Hood DB, Archibong AE, Knuckles ME, Nyanda AM. Metabolism, bioavailability, and toxicokinetics of benzo[a]pyrene [BaP] in F-344 rats following oral administration. Exp Toxicol Pathol. 2001;53:253–70.CrossRef
28.
Hakami R, Mohtadinia J, Etemadi A, et al. Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer. 2008;60:216–21.CrossRefPubMed
29.
Martorell I, Nieto A, Nadal M, et al. Human exposure to polycyclic aromatic hydrocarbons (PAHs) using data from a duplicate diet study in Catalonia, Spain. Food Chem Toxicol. 2012;50:4103–8.CrossRefPubMed
30.
Duarte-Salles T, Mendez MA, Pessoa V, et al. Smoking during pregnancy is associated with higher dietary intake of polycyclic aromatic hydrocarbons and poor diet quality. Public Health Nutr. 2010;13:2034–43.CrossRefPubMed
31.
Pleil JD, Stiegel MA, Sobus JR, et al. Cumulative exposure assessment for trace-level polycyclic aromatic hydrocarbons (PAHs) using human blood and plasma analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:1753–60.CrossRefPubMed
32.
Hutcheon DE, Kantrowitz J, Van Gelder RN, Flynn E. Factors affecting plasma benzo[a]pyrene levels in environmental studies. Environ Res. 1983;32:104–10.CrossRefPubMed
33.
Qin YY, Leung CK, Lin CK, et al. Halogenated POPs and PAHs in blood plasma of Hong Kong residents. Environ Sci Technol. 2011;45:1630–7.CrossRefPubMed
34.
Bolte G, Heitmann D, Kiranoglu M, et al. Exposure to environmental tobacco smoke in German restaurants, pubs and discotheques. J Expo Sci Environ Epidemiol. 2008;18:262–71.CrossRefPubMed
35.
Langlois PH, Hoyt AT, Lupo PJ, et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect-affected pregnancies. Birth Defects Res A Clin Mol Teratol. 2012;94:693–700.CrossRefPubMedPubMedCentral
36.
Dong H, Dalton TP, Miller ML, et al. Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle. Mol Pharmacol. 2009;75:555–67.CrossRefPubMed
37.
Knuckles ME, Inyang F, Ramesh A. Acute and subchronic oral toxicities of benzo[a]pyrene in F-344 rats. Toxicol Sci. 2001;61:382–8.CrossRefPubMed
38.
Uno S, Dalton TP, Dragin N, et al. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharmacol. 2006;69:1103–14.CrossRefPubMed
39.
Jiang Y, Zhou X, Chen X, et al. Benzo(a)pyrene-induced mitochondrial dysfunction and cell death in p53-null Hep3B cells. Mutat Res. 2011;726:75–83.CrossRefPubMed
40.
Ko CB, Kim SJ, Park C, et al. Benzo(a)pyrene-induced apoptotic death of mouse hepatoma Hepa1c1c7 cells via activation of intrinsic caspase cascade and mitochondrial dysfunction. Toxicology. 2004;199:35–46.CrossRefPubMed
41.
Reeve VE, Gallagher CH. Metabolism of [14C]benzo[a]pyrene in vivo in the rat. Cancer Lett. 1981;13:79–86.CrossRefPubMed
42.
Zhang QY, Wikoff J, Dunbar D, Kaminsky L. Characterization of rat small intestinal cytochrome P450 composition and inducibility. Drug Metab Dispos. 1996;24:322–8.PubMed
43.
Zhang QY, Wikoff J, Dunbar D, et al. Regulation of cytochrome P450 1A1 expression in rat small intestine. Drug Metab Dispos. 1997;25:21–6.PubMed
44.
Roos PH. Differential induction of CYP1A1 in duodenum, liver and kidney of rats after oral intake of soil containing polycyclic aromatic hydrocarbons. Arch Toxicol. 2002;76:75–82.CrossRefPubMed
45.
Diggs DL, Harris KL, Rehkadvevi PV, Ramesh A. Tumor microsomal metabolism of the food toxicant, benzo(a)pyrene, in Apc Min mouse model of colon cancer. Tumor Biol. 2012;33:1255–60.CrossRef
46.
Zhang QY, He W, Dunbar D, Kaminsky L. Induction of CYP 1A1 by β-naphthoflavone in IEC-18 rat intestinal epithelial cells and potentiation of induction by dibutyryl camp. Biochem Biophys Res Commun. 1997;233:623–6.CrossRefPubMed
47.
Buesen R, Mock M, Seidel A, et al. Interaction between metabolism and transport of benzo(a)pyrene and its metabolites in enterocytes. Toxicol Appl Microbiol. 2002;183:168–78.
48.
Buesen R, Mock M, Nau H, Seidel A, Jacob J, Lampen A. Human intestinal Caco-2 cells display active transport of benzo(a)pyrene metabolites. Chem Biol Interact. 2003;142:201–21.CrossRefPubMed
49.
Spatzenegger M, Horsmans Y, Verbeck RK. Differential activities of CYP1A isozyme in hepatic and intestinal microsomes of control and 3-methylcholanthene-induced rats. Pharmacol Toxicol. 2000;86:71–7.CrossRefPubMed
50.
Sterling Jr KM, Cutroneo KR. Differentiation-dependent induction of CYP1A1 in cultures rat small intestinal epithelial cells, colonocytes, and human colon carcinoma cells, basement membrane-mediated apoptosis. J Cell Biochem. 2002;86:440–50.CrossRefPubMed
51.
Roos PH, Tschirbs S, Hack A, et al. Different mechanisms of handling ingested polycyclic aromatic hydrocarbons in mammalian species: organ-specific response patterns of CYP1A1-induction after oral intake of PAH-contaminated soils. Xenobiotica. 2004;34:781–95.CrossRefPubMed
52.
Uno S, Dragin N, Miller ML, et al. Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract. Free Radic Biol Med. 2008;44:570–83.CrossRefPubMed
53.
Herbst U, Fuchs JI, Teubner W, Steinberg P. Malignant transformation of human colon epithelial cells by benzo[c]phenanthrene dihydrodiolepoxides as well as 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Toxicol Appl Pharmacol. 2006;212:136–45.CrossRefPubMed
54.
Wall KL, Gao W, te Koppele JM, et al. The liver plays a central role in the mechanism of chemical carcinogenesis due to polycyclic aromatic hydrocarbons. Carcinogenesis. 1991;12:783–6.CrossRefPubMed
55.
Lin JH, Chiba M, Baillie TA. Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol Rev. 1999;51:135–57.PubMed
56.
Newman JW, Morisseau C, Hammock BD. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res. 2005;44:1–51.CrossRefPubMed
57.
Kaminsky LS, Zhang Q-Y. The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos. 2003;31:1520–5.CrossRefPubMed
58.
Bolton JL, Trush MA, Penning TM, et al. Role of quinones in toxicology. Chem Res Toxicol. 2000;13:135–60.CrossRefPubMed
59.
Kim YS, Kim SJ, Oh TW, et al. Differential inhibitory effects of conjugated linoleic acid isomers on mouse forestomach neoplasia induced by benzo(a)pyrene. J Agric Food Chem. 2010;58:3177–83.CrossRefPubMed
60.
Singh M, Singh S, Kale RK. Chemomodulatory potential of Asparagus adscendens against murine skin and forestomach papillomagenesis. Eur J Cancer Prev. 2011;20:240–7.CrossRefPubMed
61.
Cross AJ, Freedman ND, Ren J, et al. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol. 2011;106:432–42.CrossRefPubMed
Metadata
Title
Metabolism of benzo(a)pyrene by subcellular fractions of gastrointestinal (GI) tract and liver in Apc Min mouse model of colon cancer
Authors
Jane A. Mantey
Perumalla V. Rekhadevi
Deacqunita L. Diggs
Aramandla Ramesh
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1647-0

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue

Research Article

Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a Russian population: a case-control study

Research Article

Relationship of serum levels of VEGF and TGF-β1 with radiosensitivity of elderly patients with unresectable non-small cell lung cancer

Research Article

Lack of association between IL-4 -588C>T polymorphism and NHL susceptibility

Research Article

Association study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil

Research Article

ERCC1 and BRCA1 mRNA expressions are associated with clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy

Research Article

RETRACTED ARTICLE: Polyamidoamine dendrimer liposome-mediated survivin antisense oligonucleotide inhibits hepatic cancer cell proliferation by inducing apoptosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits